The expanding arsenal of targeted and immuno-oncology drugs has unalterably changed the landscape of systemic cancer treatment, but chemotherapy will remain critical for years if not decades to come.
Kevin Lord, PhD, MHS
Advertisement
Articles by Kevin Lord, PhD, MHS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
First-Line Vitiligo Treatment: Topical JAK Inhibitors and Phototherapy
2
Unanswered Questions in First- and Second-Line mCRC Care
3
Cleveland Clinicians Say Obesity Care Starts Too Late for Many Patients
4
Precision Drugs Meet Payer Realities
5